Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,169.9
9.2 (0.29%)

 

  • STI Straits Times Index
    3,169.9
    9.2 (0.29%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,598.3
    -3.5 (-0.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,353.9
    86.8 (0.32%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,853.0
    0.5 (0.02%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,117.2
    -33.9 (-0.16%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,057.4
    24.7 (0.41%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,045.3
    -14.3 (-0.69%)
    Index delayed 20 minutes
  • XAO XAO
    6,545.6
    -38.7 (-0.59%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 695.3M
  • Value: 914.3M
  • Rise: 177
  • Fall: 116
  • Unch: 548

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
YZJ Shipbldg SGD1.370-0.010
ISR Capital^0.002-
Golden Agri-Res0.265-0.010
AA0.010-0.003
Eagle HTrust USD0.730-
Genting Sing0.870-0.005
CapitaCom Trust1.920-
Asian Pay Tv Tr0.177+0.004
Rex Intl0.063+0.001
SingTel3.150+0.030

World Indices

World Indices
Name Last Change
Nasdaq 7,628.3 -122.6
HSI 27,353.9 +86.8
HSCEI 10,445.5 +44.4
Jakarta 6,057.4 +24.7
Nikkei 225 21,117.2 -33.9
SSE Comp 2,853.0 +0.5
Shanghai A 2,988.1 +0.6
Shanghai B 285.8 -2.1
ShenZhen A 1,564.5 -7.7
ShenZhen B 931.3 -1.4
Taiwan W 10,328.3 +19.9
PSE Comp 0.0
KOSPI 2,045.3 -14.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Hyphens Pharma HYPHENS PHARMA INTL LIMITED
Quotes 10 Minutes Delayed. Updated at 24 May 2019 17:04
Last (SGD): 0.198 Change: -0.002 High: 0.199 Remarks: -
Change (%): -1.00 Low: 0.198
Open 0.199 Yesterday's Close 0.200
Buy Price 0.198 Sell Price 0.200
Buy Volume ('000) 113.0 Sell Volume ('000) 35.0
Cumulative Volume ('000) 120.0 Cumulative Value 23,838
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.01801 Trailing EPS (SGD) e 0.01801 NAV (SGD) b 0.1352
PE a 10.994 Trailing PE f 10.995 Price / NAV b 1.4645
Dividend (SGD) d 0.005492 Cash In Hand (SGD) g 0.0737 Issued & Paid-up Shares c 300,430,000
Dividend Yield (%) d 2.774 Price / Cash In Hand g 2.687 Treasury Shares h -
Beta - 75 Daysi 0.013 R-Squared - 75 Days(%)i - Market Cap (M) 59.485
Beta - 500 Daysi 0.292 R-Squared - 500 Days (%)i 0.73 Enterprise Value (M) 42.069
Piotroski F Score - Exchange Code 1J5 Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 34.2001 6-Month VWAP 0.209 Free Float (%) 20.0
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Commerce - Pharmaceuticals: Major
Category Classification Medical & Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 16 May 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Hyphens Pharma SGX 59.485 10.994 10.995 1.4645 2.774
Industry Medical & Biotechnology SGX 994.909 22.755 19.857 1.0965 1.893
Pharmaceuticals: Major SGX 33.436 8.645 8.680 0.9367 2.467
Local Peer Star Pharm^ SGX 7.386 3.177 3.220 0.2400 -
Global Peer JOHNSON & JOHNSON NYSE 371,150.837 24.263 25.284 6.2955 2.539
Global Peer PFIZER INC NYSE 232,731.456 20.869 30.610 3.9589 3.390
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 215,375.197 17.039 17.452 4.5602 1.977
Global Peer MERCK & CO INC NYSE 208,597.333 33.537 24.836 7.5746 2.473
Global Peer ABBVIE INC NYSE 119,966.480 21.207 22.508 -15.3293 4.869
Global Peer ELI LILLY AND COMPANY NYSE 113,402.769 35.087 44.026 45.7218 2.097
Global Peer SANOFI SPON ADS ECH REP 1/2 ORD EUR2 LEVEL II NASDAQ 105,055.607 20.618 20.618 1.5609 2.768
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 101,425.283 47.145 42.224 9.6752 3.423
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 99,731.061 20.644 19.588 19.0674 5.089
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 90,110.653 14.738 15.140 12.6613 2.373
Other Global Peers BRISTOL-MYERS SQUIBB CO (NYSE), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), CHINARES PHARMA (HKEx), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), HUTCHISON CHINA MEDITECH SPON ADR EACH REPR 0.50 ORD SHS (NASDAQ), INNOVENT BIO-B (HKEx), JUNSHI BIO-B (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), REATA PHARMACEUTICALS INC (NASDAQ), AMNEAL PHARMACEUTICALS INC (NYSE), CMS (HKEx), AKCEA THERAPEUTICS INC (NASDAQ), ALLAKOS INC (NASDAQ), TRICIDA INC (NASDAQ), CHINAGRANDPHARM (HKEx), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CSTONE PHARMA-B (HKEx), GOSSAMER BIO INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), ATHENEX INC (NASDAQ), RA PHARMACEUTICALS INC (NASDAQ), HUA MEDICINE-B (HKEx), CANSINOBIO-B (HKEx), UNITED LAB (HKEx), NIGHTSTAR THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), PETIQ INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), PRINCIPIA BIOPHARMA INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), ODONATE THERAPEUTICS LLC (NASDAQ), ZYMEWORKS INC (NYSE), OBSEVA SA (NASDAQ), AKORN INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), FUSEN PHARM (HKEx), IGBB (Bursa), CYCLERION THERAPEUTICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), FORTY SEVEN INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), AC IMMUNE SA (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), NC HEALTHCARE (HKEx), DOVA PHARMACEUTICALS INC (NASDAQ), DAWNRAYS PHARMA (HKEx), PHASEBIO PHARMACEUTICALS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), LANNETT CO INC (NYSE), EVELO BIOSCIENCES INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), THE FS ALSEC ALPHASECTOR (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), IDEAYA BIOSCIENCES INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), XYNOMIC PHARMACEUTICALS HLDGS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), MUSTANG BIO INC (NASDAQ), Merck Tbk. (IDX), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), Phapros Tbk. (IDX), SPRING BANK PHARMACEUTICALS INC (NASDAQ), AGEX THERAPEUTICS INC (NYSE American), CHARMACY PHAR (HKEx), ALLENA PHARMACEUTICALS INC (NASDAQ), IMMUNIC INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), ARCTURUS THERAPEUTICS LTD (NASDAQ), TPI ENTERPRISES LIMITED (ASX), NEP INTERLONG (HKEx), OVID THERAPEUTICS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), EYENOVIA INC (NASDAQ), MEDLAB CLINICAL LIMITED (ASX), KOTRA (Bursa), NOVAN INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), NOXOPHARM LTD (ASX), HOTH THERAPEUTICS INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), ENTERA BIO LTD (NASDAQ), BIOHLDG (Bursa), CRESO PHARMA LTD (ASX), SINOLIFE UTD (HKEx), SIENNA BIOPHARMACEUTICALS INC (NASDAQ), MMJ GROUP HOLDINGS LTD (ASX), ADYNXX INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), TELIGENT INC NEW (NASDAQ), NOVA (Bursa), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), ZOMEDICA PHARMACEUTICALS CORP (NYSE American), CITIUS PHARMACEUTICALS INC (NASDAQ), EXOPHARM LTD (ASX), AILERON THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), GEMPHIRE THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), FARMAFORCE LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX), FIJI KAVA LTD (ASX), RACE ONCOLOGY LTD (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.002
-1.00 %
10 Days 0.006-0.012
-2.86 %
20 Days 0.006-0.017
-5.12 %
Medium Term Return 3 Months 0.006+0.022
+15.91 %
6 Months 0.006-0.002
+2.00 %
1 Year 0.006-0.062
-21.54 %
Annualised Return Annualised --
-21.54 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.160 - 0.275 Change From 1 Year Low +0.038 % Change From 1 Year Low (%) +23.75
Change From 1 Year High -0.077 % Change From 1 Year High (%) -28.00
2 Years Range 0.160 - 0.305 Change From 2 Years Low +0.038 % Change From 2 Years Low (%) +23.75
Change From 2 Years High -0.107 % Change From 2 Years High (%) -35.08
5 Years Range 0.160 - 0.305 Change From 5 Years Low +0.038 % Change From 5 Years Low (%) +23.75
Change From 5 Years High -0.107 % Change From 5 Years High (%) -35.08
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Hyphens Pharma International Limited and its subsidiaries (the "Group") is one of Singapore’s leading specialty pharmaceutical and consumer healthcare groups leveraging on its diverse footprint in ASEAN countries. The Group has a direct presence in five ASEAN countries, namely, Singapore, Vietnam, Malaysia, Indonesia and the Philippines, supplemented by a marketing and distribution network covering five additional jurisdictions, namely, Hong Kong, Myanmar, Brunei, Cambodia and Oman. Singapore is the Group’s regional headquarters, where its strategic planning, finance, regulatory affairs, research and development, legal, business development and logistics operations are based.

The Group’s core business comprises the following segments: specialty pharma principals, proprietary brands, and medical hypermart and digital. Besides marketing and selling a range of specialty pharmaceutical products in selected ASEAN countries through exclusive distributorship or licensing and supply agreements with brand principals mainly from Europe and the United States, the Group also develops, markets and sells its own proprietary range of dermatological products and health supplement products. In addition, the Group operates a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies, to supply pharmaceutical products and medical supplies.

IPO Performance

Listing Date 18 May 2018 Full Subscription Rate (x) 17.91
No of Placement Shares (M) 23.79 No of Public Offer Shares (M) 3.00 Public Offer Subscription Rate (x) 151.99
IPO Price (SGD) a 0.260 First Day Close (SGD) a 0.275 First Week Close (SGD) a 0.260
Current vs IPO Price (%) -23.85 First Day Gain (%) +5.77 First Week Gain (%) -
Notes:
  1. Adjusted for the following: 23,790,000 Placement Shares do not include the 2,810,000 Reserved Shares.

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(7.14 MB)
IPO Prospectus
IPO Prospectus 2018 May 2018 Part 1(2.57 MB)
Part 2(0.27 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
24 May 2019 0.199 0.199 0.198 0.198 120,000 0.1987
23 May 2019 0.200 0.200 0.200 0.200 50,000 0.2000
22 May 2019 0.205 0.205 0.205 0.205 25,000 0.2050
21 May 2019 0.205 0.205 0.205 0.205 50,000 0.2050
17 May 2019 0.200 0.200 0.200 0.200 20,000 0.2000
16 May 2019 0.200 0.200 0.200 0.200 - -
15 May 2019 0.200 0.200 0.200 0.200 108,000 0.2000
14 May 2019 0.205 0.205 0.198 0.198 512,900 0.2012
13 May 2019 0.210 0.210 0.210 0.210 29,400 0.2100
10 May 2019 0.215 0.215 0.210 0.210 133,100 0.2150
09 May 2019 0.220 0.220 0.215 0.220 40,000 0.2163
08 May 2019 0.215 0.225 0.215 0.225 21,100 0.2198
07 May 2019 0.215 0.215 0.215 0.215 12,500 0.2150
06 May 2019 0.210 0.210 0.210 0.210 27,000 0.2100
03 May 2019 0.215 0.215 0.215 0.215 43,700 0.2150
02 May 2019 0.215 0.215 0.210 0.210 35,200 0.2100
30 Apr 2019 0.210 0.210 0.205 0.205 39,000 0.2097
29 Apr 2019 0.210 0.210 0.210 0.210 104,000 0.2100
26 Apr 2019 0.215 0.215 0.215 0.215 - -
25 Apr 2019 0.220 0.220 0.215 0.215 16,500 0.2155
24 Apr 2019 0.215 0.215 0.215 0.215 45,000 0.2150
23 Apr 2019 0.215 0.215 0.215 0.215 10,000 0.2150
Summary
Current 2 Weeks
(10 May 2019 to 24 May 2019)
0.215 0.215 0.198 0.198 1,048,400 -
Previous 2 Weeks
(25 Apr 2019 to 09 May 2019)
0.220 0.220 0.198 0.220 339,000 -
4 Weeks from
(27 Mar 2019 to 24 Apr 2019)
0.200 0.215 0.198 0.215 586,500 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.